PHOENIX -- The newer generation Evolut transcatheter aortic valve replacement (TAVR) device improved on procedural and possibly safety characteristics, the TVT registry showed. The Evolut FX device ...

Please provide your email address to receive an email when new articles are posted on . In a real-world setting, a next-generation self-expanding transcatheter aortic valve replacement system showed ...

Medtronic plc’s MDT Evolut PRO+, the next-generation Transcatheter Aortic Valve Replacement (TAVR) system, has won the FDA approval. The company also announced the commercial launch of this device, ...

ATLANTA -- For transcatheter aortic valve replacement (TAVR) candidates with a small aortic annulus, the two leading platforms offered differing hemodynamic valve performances despite being similarly ...

DUBLIN, May 3, 2021 /CNW/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced CE (Conformité Européenne) Mark of the Evolut™ PRO+ TAVI System – the newest-generation ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Please provide your email address to receive an email when new articles are posted on . Medtronic announced that a new-generation transcatheter aortic valve replacement system has been approved by the ...

WASHINGTON, DC—Amid growing calls to consider coronary access as part of heart team discussions, a new analysis is shining a light on which devices will not impair subsequent coronary procedures and ...

Medtronic is kicking off the nationwide rollout of the latest generation of its transcatheter aortic valve replacement system, the Evolut FX. The TAVR implant first received approval to treat aortic ...

Medtronic plc’s (NYSE:MDT) Evolut PRO+, the next-generation Transcatheter Aortic Valve Replacement (TAVR) system, has won the FDA approval. The company also announced the commercial launch of this ...